BOSTON & TARRYTOWN, N.Y. -- -- Resilience Therapeutics, Inc. and PGI Drug Discovery LLC , today announced that they have entered into a partnership to discover and optimize novel treatments for Post-Traumatic Stress Disorder and related conditions. Under the terms of the agreement, PsychoGenics, which has made a strategic investment in Resilience, is providing access to their powerful discovery technology platforms including its SmartCube system, and expertise for the development of novel therapeutics for PTSD and other stress-related disorders.
http://ift.tt/1BxTQv0
http://ift.tt/1BxTQv0
No comments:
Post a Comment